Edge Wealth Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-35,000
| Closed | -$448K | – | 87 |
|
|
2022
Q3 | $448K | Hold |
35,000
| – | – | 0.1% | 55 |
|
|
2022
Q2 | $370K | Hold |
35,000
| – | – | 0.08% | 59 |
|
|
2022
Q1 | $569K | Hold |
35,000
| – | – | 0.11% | 57 |
|
|
2021
Q4 | $485K | Buy |
35,000
+10,000
| +40% | +$139K | 0.09% | 67 |
|
|
2021
Q3 | $359K | Sell |
25,000
-25,000
| -50% | -$359K | 0.07% | 76 |
|
|
2021
Q2 | $794K | Hold |
50,000
| – | – | 0.16% | 58 |
|
|
2021
Q1 | $509K | Sell |
50,000
-60,010
| -55% | -$611K | 0.11% | 66 |
|
|
2020
Q4 | $822K | Sell |
110,010
-111,619
| -50% | -$834K | 0.19% | 58 |
|
|
2020
Q3 | $761K | Buy |
221,629
+35,700
| +19% | +$123K | 0.18% | 61 |
|
|
2020
Q2 | $886K | Buy |
+185,929
| New | +$886K | 0.17% | 73 |
|